Detalhe da pesquisa
1.
Rationalizing the Use of COVID-19 Questionable Efficacy Drugs in a Low Middle-income Country: A Hospital Tocilizumab Committee Experience.
J Assoc Physicians India
; 71(3): 11-12, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354501